133 related articles for article (PubMed ID: 27000530)
1. Liquid liothyronine to obtain target TSH in differentiated thyroid cancer patients.
Trimboli P; Centanni M; Virili C
Endocr J; 2016 Jun; 63(6):563-7. PubMed ID: 27000530
[TBL] [Abstract][Full Text] [Related]
2. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters.
Jonklaas J; Burman KD
Thyroid; 2016 Jun; 26(6):770-8. PubMed ID: 27030088
[TBL] [Abstract][Full Text] [Related]
3. TSH levels and TSH response to TRH as a guide to the replacement treatment of patients with thyroid carcinoma.
Busnardo B; Vagelista R; Girelli ME; Bui F; Lazzi C
J Clin Endocrinol Metab; 1976 May; 42(5):901-6. PubMed ID: 818103
[TBL] [Abstract][Full Text] [Related]
4. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
5. Preparation for radioactive iodine administration in differentiated thyroid cancer patients.
Liel Y
Clin Endocrinol (Oxf); 2002 Oct; 57(4):523-7. PubMed ID: 12354135
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
7. The comparative effect of T4 and T3 on the TSH response to TRH in young adult men.
Sawin CT; Hershman JM; Chopra IJ
J Clin Endocrinol Metab; 1977 Feb; 44(2):273-8. PubMed ID: 402379
[TBL] [Abstract][Full Text] [Related]
8. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
[TBL] [Abstract][Full Text] [Related]
10. Timing of Hormone Withdrawal in Children Undergoing 131I Whole-Body Scans for Thyroid Cancer.
Turpin S; Lambert R; Deal C
Horm Res Paediatr; 2016; 86(6):410-415. PubMed ID: 27902975
[TBL] [Abstract][Full Text] [Related]
11. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
Jonklaas J; Davidson B; Bhagat S; Soldin SJ
JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
[TBL] [Abstract][Full Text] [Related]
12. Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine.
Edmonds CJ; Hayes S; Kermode JC; Thompson BD
Br J Radiol; 1977 Nov; 50(599):799-807. PubMed ID: 588901
[TBL] [Abstract][Full Text] [Related]
13. The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.
Celi FS; Zemskova M; Linderman JD; Babar NI; Skarulis MC; Csako G; Wesley R; Costello R; Penzak SR; Pucino F
Clin Endocrinol (Oxf); 2010 May; 72(5):709-15. PubMed ID: 20447070
[TBL] [Abstract][Full Text] [Related]
14. Highly sensitive determination of TSH in the follow-up of TSH-suppressive therapy of patients with differentiated thyroid cancer.
Mann K; Saller B; Mehl U; Hörmann R; Moser E
Nuklearmedizin; 1988 Feb; 27(1):24-8. PubMed ID: 3368333
[TBL] [Abstract][Full Text] [Related]
15. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin-releasing hormone and thyroid hormone interactions on thyrotropin secretion in the rat: lack of inhibiting effects of small doses of triiodo-L-thyronine in the hypothyroid rat.
García MD; Escobar del Rey F; Morreale de Escobar G
Endocrinology; 1976 Jan; 98(1):203-13. PubMed ID: 813987
[TBL] [Abstract][Full Text] [Related]
17. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
18. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.
Geffner DL; Azukizawa M; Hershman JM
J Clin Invest; 1975 Feb; 55(2):224-9. PubMed ID: 805160
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of adequacy of levo-thyroxine dosage in patients with differentiated thyroid carcinoma: correlation between morning and afternoon TSH determination.
Conte L; Monti E; Gay S; Marroni P; Adorno A; Mittica M; Mussap M; Giusti M
J Endocrinol Invest; 2018 Oct; 41(10):1193-1197. PubMed ID: 29476411
[TBL] [Abstract][Full Text] [Related]
20. Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok.
Thewjitcharoen Y; Chatchomchuan W; Wanothayaroj E; Butadej S; Nakasatien S; Krittiyawong S; Rajatanavin R; Himathongkam T
Medicine (Baltimore); 2024 May; 103(21):e38290. PubMed ID: 38788029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
